IDEXX Laboratories, Inc. (IDXX): Price and Financial Metrics

IDEXX Laboratories, Inc. (IDXX)

Today's Latest Price: $384.83 USD

10.80 (2.89%)

Updated Aug 12 4:00pm

Add IDXX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

IDXX Stock Summary

  • IDXX has a market capitalization of $31,813,000,838 -- more than approximately 93.96% of US stocks.
  • Idexx Laboratories Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 96.22% of US listed stocks.
  • Price to trailing twelve month operating cash flow for IDXX is currently 60.75, higher than 94.42% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to Idexx Laboratories Inc, a group of peers worth examining would be CFMS, CLX, MTD, PII, and RMTI.
  • IDXX's SEC filings can be seen here. And to visit Idexx Laboratories Inc's official web site, go to
IDXX Daily Price Range
IDXX 52-Week Price Range

IDXX Stock Price Chart Technical Analysis Charts

IDXX Price/Volume Stats

Current price $384.83 52-week high $407.86
Prev. close $374.03 52-week low $168.65
Day low $375.02 Volume 444,192
Day high $387.84 Avg. volume 598,046
50-day MA $343.03 Dividend yield N/A
200-day MA $284.56 Market Cap 32.73B

IDEXX Laboratories, Inc. (IDXX) Company Bio

IDEXX Laboratories develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. The company was founded in 1983 and is based in Westbrook, Maine.

IDXX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$384.83$56.86 -85%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Idexx Laboratories Inc. To summarize, we found that Idexx Laboratories Inc ranked in the 15th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 84.83%. The most interesting components of our discounted cash flow analysis for Idexx Laboratories Inc ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is 18.74 -- which is good for besting 82.83% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately just 11.05% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • IDXX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 48.44% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Idexx Laboratories Inc? See ABMC, COO, NUVA, BSX, and ELAN.

IDXX Latest News Stream

Event/Time News Detail
Loading, please wait...

IDXX Latest Social Stream

Loading social stream, please wait...

View Full IDXX Social Stream

Latest IDXX News From Around the Web

Below are the latest news stories about Idexx Laboratories Inc that investors may wish to consider to help them evaluate IDXX as an investment opportunity.

Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?

IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | July 30, 2020

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | July 21, 2020

Are You Looking for a Top Momentum Pick? Why Idexx Laboratories (IDXX) is a Great Choice

Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Yahoo | July 21, 2020

IDEXX Laboratories to Release 2020 Second Quarter Financial Results and Host Virtual Investor Day

WESTBROOK, Maine, July 20, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 second quarter financial results for Friday, July 31, 2020…

PR Newswire | July 20, 2020

Did Hedge Funds Make The Right Call On IDEXX Laboratories, Inc. (IDXX) ?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]

Yahoo | July 14, 2020

Read More 'IDXX' Stories Here

IDXX Price Returns

1-mo 13.70%
3-mo 30.73%
6-mo 33.26%
1-year 42.63%
3-year 147.77%
5-year 395.85%
YTD 47.37%
2019 40.38%
2018 18.95%
2017 33.35%
2016 60.82%
2015 -1.64%

Continue Researching IDXX

Here are a few links from around the web to help you further your research on Idexx Laboratories Inc's stock as an investment opportunity:

Idexx Laboratories Inc (IDXX) Stock Price | Nasdaq
Idexx Laboratories Inc (IDXX) Stock Quote, History and News - Yahoo Finance
Idexx Laboratories Inc (IDXX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9535 seconds.